| Financial Year |
March 31 2023 |
| Monetary Funds |
831,544,936.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
49,102,211.62 |
| Accounts Receivable |
1,667,030,346.60 |
| Advances to Suppliers |
168,906,713.88 |
| Other Receivables |
177,711,164.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
299,153,619.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
54,018,817.26 |
| Other Current Assets |
118,875,394.10 |
| Total Current Assets |
4,779,857,117.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
292,357,642.69 |
| Long-term Equity Investment |
346,618,642.33 |
| Investment Properties |
132,390,043.04 |
| Fixed Assetes |
1,272,149,779.13 |
| Under-construction Projects |
212,286,278.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,832,734,440.98 |
| R&D expenses |
-- |
| Goodwill |
30,697,687.72 |
| Long-Term Deferred and Prepaid Expenses |
14,450,730.77 |
| Deferred Income Tax Assets |
276,329,735.80 |
| Other Non-Current Assets |
619,178,863.89 |
| Sub-Total of Non-Current Assets |
7,061,515,400.90 |
| Total Assets |
11,841,372,518.04 |
| Short-Term Loans |
2,073,859,275.93 |
| Trading Financial liabilities |
-- |
| Notes Payable |
542,969,273.08 |
| Accounts Payable |
2,186,333,815.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
51,249,603.55 |
| Taxes Payable |
42,784,158.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
100,554,633.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
512,229,097.89 |
| Other Current Liabilities |
333,697,883.41 |
| Sub-Total of Current Liabilities |
6,331,489,903.54 |
| Long-term Loans |
1,980,880,419.96 |
| Bonds Payable |
418,585,861.95 |
| Long-Term Accounts Payable |
33,554,412.47 |
| Special Payable |
-- |
| Estimatied Liabilities |
189,039,258.25 |
| Deferred Income Tax Liabilities |
12,879,708.18 |
| Other Non-Current Liabilities |
219,034,940.79 |
| Sub-Total of Non-Current Liabilities |
3,011,738,879.25 |
| Total Liabilities |
9,343,228,782.79 |
| Paid-In Capital(Or Share Stock) |
504,872,716.00 |
| Capital Surplus |
1,631,000,677.63 |
| Surplus Reserve |
84,645,161.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-69,371,392.64 |
| Minority Stockholder's Interest |
218,784,064.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,279,359,671.10 |
| Owner's Equity（Stockholder's Equity） |
2,498,143,735.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,841,372,518.04 |
